この Link あなたの言語には存在しません, で見る: English (en),
またはGoogle翻訳を使用する:  

https://www.mdpi.com/1420-3049/28/17/6221

Cheng, Xiaotian, Minni Qin, Rongrong Chen, Yunxia Jia, Qing Zhu, Guangtong Chen, Andong Wang, Bai Ling, and Weiwei Rong. 2023. "Citrullus colocynthis (L.) Schrad.: A Promising Pharmaceutical Resource for Multiple Diseases" Molecules 28, no. 17: 6221. https://doi.org/10.3390/molecules28176221

Citrullus colocynthis (L.) Schrad. (Cucurbitaceae) is widely distributed in the desert areas of the world. The fruit bodies of C. colocynthis are recognized for their wide range of nutraceutical potential, as well as medicinal and pharmaceutical uses. The plant has been reported for various uses, such as asthma, bronchitis, cancer, colic, common cold, cough, diabetes, dysentery, and jaundice. The fruit has been extensively studied for its biological activities, which include insecticide, antitumor, and antidiabetic effects. Numerous bioactive compounds have been reported in its fruit bodies, such as essential oils, fatty acids, glycosides, alkaloids, and flavonoids. Of these, flavonoids or caffeic acid derivatives are the constituents associated with the inhibition of fungal or bacterial growth, whereas eudesmane sesquiterpenes or sesquiterpene lactones are most active against insects, mites, and nematodes. In this review, the scientific evidence for the biological activity of C. colocynthis against insecticide, cytotoxic, and antidiabetic effects is summarized.

Keywords: Citrullus colocynthis (L.) Schrad.Cucurbitaceaeinsecticideantitumorantidiabetic effect